| Literature DB >> 33027802 |
Nikolaos Koutsouleris1, Lana Kambeitz-Ilankovic2,3, Shalaila S Haas4, Linda A Antonucci1,5, Julian Wenzel6, Anne Ruef1, Bruno Biagianti7,8, Marco Paolini9, Boris-Stephan Rauchmann1,9, Johanna Weiske1, Joseph Kambeitz6, Stefan Borgwardt10, Paolo Brambilla11,12, Eva Meisenzahl13, Raimo K R Salokangas14, Rachel Upthegrove15,16, Stephen J Wood15,17,18.
Abstract
Two decades of studies suggest that computerized cognitive training (CCT) has an effect on cognitive improvement and the restoration of brain activity. Nevertheless, individual response to CCT remains heterogenous, and the predictive potential of neuroimaging in gauging response to CCT remains unknown. We employed multivariate pattern analysis (MVPA) on whole-brain resting-state functional connectivity (rsFC) to (neuro)monitor clinical outcome defined as psychosis-likeness change after 10-hours of CCT in recent onset psychosis (ROP) patients. Additionally, we investigated if sensory processing (SP) change during CCT is associated with individual psychosis-likeness change and cognitive gains after CCT. 26 ROP patients were divided into maintainers and improvers based on their SP change during CCT. A support vector machine (SVM) classifier separating 56 healthy controls (HC) from 35 ROP patients using rsFC (balanced accuracy of 65.5%, P < 0.01) was built in an independent sample to create a naturalistic model representing the HC-ROP hyperplane. This model was out-of-sample cross-validated in the ROP patients from the CCT trial to assess associations between rsFC pattern change, cognitive gains and SP during CCT. Patients with intact SP threshold at baseline showed improved attention despite psychosis status on the SVM hyperplane at follow-up (p < 0.05). Contrarily, the attentional gains occurred in the ROP patients who showed impaired SP at baseline only if rsfMRI diagnosis status shifted to the healthy-like side of the SVM continuum. Our results reveal the utility of MVPA for elucidating treatment response neuromarkers based on rsFC-SP change and pave the road to more personalized interventions.Entities:
Year: 2020 PMID: 33027802 PMCID: PMC8027389 DOI: 10.1038/s41386-020-00877-4
Source DB: PubMed Journal: Neuropsychopharmacology ISSN: 0893-133X Impact factor: 7.853
Baseline demographic and clinical characteristics for ROP patients and HC individuals included for the generation of a healthy-to-psychosis model based on resting-state functional connectivity.
| ROP ( | HC ( | |||
|---|---|---|---|---|
| Number of female (%) | 13 (37.14 %) | 36 (64.29 %) | 6.39 | 0.012* |
| Age ( | 30.43 (6.15) | 30.64 (6.78) | 0.151 | 0.88 |
| Years education ( | 13.88 (3.45) | 15.73 (3.26) | 2.51 | 0.014* |
| Premorbid IQ ( | 100.29 (18.59) | 109.64 (13.24) | 2.80 | 0.006** |
| Handednessa | – | – | 0.27 | 0.88 |
| Right (%) | 29 | 47 | – | – |
| Mixed (%) | 2 | 5 | – | – |
| Left (%) | 2 | 3 | – | – |
| Diagnosis (%) | ||||
| No Axis I Diagnosis | 0 | 56 | – | – |
| Schizophrenia | 19 (54.29 %) | – | – | – |
| Schizoaffective disorder | 1 (2.63 %) | – | – | – |
| Schizophreniform disorder | 3 (8.57 %) | – | – | – |
| Delusional disorder | 5 (13.16 %) | – | – | – |
| Psychotic disorder NOS | 5 (13.16 %) | – | – | – |
| Substance-induced psychotic disorder | 2 (5.26 %) | – | – | – |
| GAF past month | 41.18 (9.87) | 83.7 (5.11) | 26.91 | <0.001*** |
| GF current | ||||
| Role ( | 5.06 (1.82) | 8.29 (0.59) | 12.24 | <0.001*** |
| Social ( | 5.65 (1.32) | 8.25 (0.69) | 12.24 | <0.001*** |
| PANSS | ||||
| Total (SD) | 67.03 (14.45) | – | – | – |
| Positive (SD) | 18.00 (5.48) | – | – | – |
| Negative (SD) | 15.06 (5.82) | – | – | – |
| General (SD) | 33.97 (6.76) | – | – | – |
MRI Magnetic Resonance Imaging, NOS not otherwise specified, MDD Major Depressive Disorder, CPZ chlorpromazine equivalent, GAF Global Assessment of Functioning, GF Global Functioning, PANSS Positive and Negative Syndrome Scale.
aTwo participants did not provide total years of education at baseline and three did not complete the self-rating instrument which includes information regarding handedness.
Baseline demographic information of the intervention sample.
| Maintainers EMT ( | Improvers EMT ( | |||
|---|---|---|---|---|
| Number of female (%) | 8 (57.14%) | 3 (25.00%) | 2.74 | 0.098 |
| Age ( | 27.46 (5.84) | 26.10 (7.00) | 0.54 | 0.594 |
| Years education ( | 14.96 (2.71) | 15.79 (4.73) | −0.56 | 0.582 |
| Premorbid IQ ( | 97.14 (16.02) | 100.83 (13.62) | −0.63 | 0.537 |
| Handedness | – | – | 2.20 | 0.333 |
| Right (%) | 9 | 11 | – | – |
| Mixed (%) | 2 | 0 | – | – |
| Left (%) | 1 | 1 | – | – |
| Diagnosis | – | – | 6.55 | 0.477 |
| Schizophrenia (%) | 4 (28.57 %) | 4 (33.33 %) | – | – |
| Schizoaffective disorder (%) | 1 (7.14 %) | - | – | – |
| Schizophreniform disorder (%) | 1 (7.14 %) | 2 (16.67 %) | – | – |
| Brief psychotic disorder (%) | 3 (21.43 %) | 3 (25.00 %) | – | – |
| Delusional disorder (%) | 1 (7.14 %) | 2 (16.67 %) | – | – |
| Psychotic disorder NOS (%) | 1 (7.14%) | – | – | – |
| MDD with psychotic symptoms (%) | 3 (21.43 %) | – | – | – |
| Substance-induced psychotic disorder (%) | – | 1 (8.33 %) | – | – |
| Medication at baseline ( | ||||
| CPZ equivalent (SD) | 142.68 (162.49) | 278.44 (258.96) | −1.63 | 0.117 |
| Days between assessments | 51.29 (13.12) | 47.42 (8.99) | 0.86 | 0.397 |
| Number of hours trained | 9.91 (0.74) | 10.10 (0.73) | −0.49 | 0.630 |
| GAF past month | 46.25 (13.86) | 48.00 (16.87) | −0.29 | 0.774 |
| GF current | ||||
| Role ( | 4.57 (1.45) | 4.25 (1.54) | 0.55 | 0.590 |
| Social ( | 6.00 (1.30) | 6.00 (0.95) | 0.00 | 1.000 |
| PANSS | ||||
| Total (SD) | 66.07 (15.61) | 69.83 (17.94) | −0.57 | 0.573 |
| Positive (SD) | 19.21 (6.12) | 19.83 (5.88) | −0.26 | 0.796 |
| Negative (SD) | 13.43 (5.24) | 15.83 (6.19) | −1.07 | 0.294 |
| General (SD) | 33.43 (9.10) | 34.17 (9.11) | −0.21 | 0.839 |
EMT Emotion Matching Task, MRI Magnetic Resonance Imaging, NOS not otherwise specified, MDD Major Depressive Disorder, CPZ chlorpromazine equivalent, GAF Global Assessment of Functioning, GF Global Functioning, PANSS Positive and Negative Syndrome Scale.
Fig. 1Proposed model depicting the application of a healthy-to-psychosis-like spectrum that could be used for monitoring treatment response to CCT.
rsFC correlation matrices are entered into the SVM classification model to distinguish HC from ROP in an external sample. Using OOCV, the model is validated on patients who underwent the intervention sample at two time-points. Changes in decision scores are compared at the two time-points (FU-T0) in order to measure the direction of shift across the hyperplane based on rsFC.
Fig. 2Depiction of the cross-validation ratio-based most reliable connections driving the classification between HC and ROP.
The inter- and intrahemispheric connectivities of the top 20 features were extracted using a percentile rank of ~99.99% mapped onto the brain using BrainNet Viewer. Details of the regions that comprise the top 20 features are depicted in Table S8 in the Supplement. Blue lines indicate higher connectivity degree in the HC group; red lines indicate greater connectivity in the ROP group. Reliability is defined as the mean value of the SVM weight divided by its standard error across all the generated models in the cross-validation scheme.
Fig. 3Decision scores and cognitive changes following computerized cognitive training.
a SVM decision score change, reflecting the degree of psychosis-likeness based on resting-state functional connectivity (rsFC), in maintainers versus improvers and b attentional change based on shift across the hyperplane using rsFC and sensory processing change. Higher SVM decision scores reflect more psychosis-like rsFC. Error bars represent standard error. EMT Emotion Matching Task, FU follow-up, HC healthy control, ROP recent onset psychosis, SVM Support Vector Machine, T0 baseline.